• Written by: (Investorideas.com newswire, breaking stock market
  • Tue, 8 Nov 2022
  •   United States

Halifax, Nova Scotia - November 8, 2022 (Newsfile Corp.) (Investorideas.com Newswire) Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) is pleased to announce that it has entered into a memorandum of understanding to evaluate, and if determined effective, to commercialize its bovine tuberculosis rapid test.

Nanotechnology Stock News: Sona (CSE: SONA) Signs MOU for Bovine TB Test Development and Commercialization